Aperam update on Q1 2025 market & financial trends

03.04.25 06:59 Uhr

Werte in diesem Artikel
Aktien

24,86 EUR -2,30 EUR -8,47%

Aperam S.A. / Key word(s): Miscellaneous
Aperam update on Q1 2025 market & financial trends

03-Apr-2025 / 06:59 CET/CEST

Wer­bung


Aperam update on Q1 2025 market & financial trends

 

Wer­bung

Luxembourg, April 3, 2025 (07:00 CEST) - In preparation of the upcoming quarterly results release scheduled for Wednesday, 30 April 2025, we would like to remind market participants of the standing guidance, earnings drivers and events that should be considered.

The Q1 2025 outlook, as specified in the Q4 2024 presentation, the management podcast and during the conference call was:

Wer­bung

  • Q1 2025 group adjusted EBITDA lower than Q4 2024 (EUR116m) despite seasonally higher shipments in Europe and the first time consolidation of Universal. These positive effects will be more than offset by pricing pressure in Europe, a clearly negative valuation effect and the seasonal trough in Brazil.
  • The Aperam compiled Q1 2025 adjusted EBITDA consensus stands at EUR87m (average) currently. The consensus is updated & published at:
    https://www.aperam.com/investors/news-contacts/results
  • Higher net financial debt versus the EUR544m reported at year end 2024 due to the acquisition of Universal Stainless & Alloy Products for USD537m (€518m) and seasonally higher net working capital. Capex was guided at EUR200m for 2025 with a higher share being spent in Q1. As a consequence of higher NWC and a high capex spend we project a negative free cash flow for first quarter  2025.

 

 

Additional items

 

Volume seasonality

Europe: Normal seasonality with higher Q1 volumes compared to Q4, which was partly due to restocking. Demand remains at a depressed level overall. In Brazil Q1 forms the seasonal trough with lower shipments qoq.

Current trading & outlook

In Europe pricing pressure remained high in Q1 and realized pricing declined versus Q4. Recent political initiatives improved the sentiment, but actual trading remains unchanged so far.
In Brazil demand remains solid as we harvest positive effects from the hot rolling mill upgrade. Q2 is a seasonally stronger quarter.

Commodity prices & valuation effect

For the group we guided for a meaningful negative valuation effect of EUR15 - 20m versus Q4.

Universal Stainless

Full consolidation started with closing on 23 January 2025 - reported within the Alloys & Specialties segment. Q1 performance reflects the clogged aerospace supply chain in the USA.

Leadership Journey Phase 5

On track to realise the target gains of EUR75m in 2025.

 

Please note that forward guidance for adjusted EBITDA, cash flow and net debt is always provided on a stable commodity price assumption.

 

 

 

 

Commodity prices & FX

 

 

DEC 24

JAN 25

FEB 25

MAR 25

Nickel LME

USD/t

15,434

15,883

15,284

16,025

Ferrochrome

USD/t

2,466

2,491

2,524

2,568

EU Stainless Scrap

USD/t

1,314

1,318

1,294

1,356

EU Stainless CR 2mm 304

USD/t

2,675

2,652

2,676

2,747

USD/EUR

x

1.05

1.07

1.04

1.08

USD/BRL
Source: Bloomberg, CRU

 

x

6,10

5.78

 

5.77

5.77

 

The Q1 2025 Financial performance will be published post market close on Wednesday, 30 April 2025.

 

Aperam management will host a conference call for members of the investment community to discuss the
Q1 2025 financial performance on 30 April 2025 at 18:30 CEST

 

 

The Capital Markets Day initially planned for June has to be postponed for scheduling reasons. We will inform you as soon as a new date has been set.

 

 

 

 

 

Forward Looking Statements

This document may contain forward-looking information and statements about Aperam SA and its subsidiaries. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future operations, products and services, and statements regarding future performance. Forward-looking statements may be identified by the words ‘’believe’’, ‘’expect’’, ‘’anticipate’’, ‘’target’’ or similar expressions. Although Aperam’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors and holders of Aperam’s securities are cautioned that forward-looking information and statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of Aperam, that could cause actual results and developments to differ materially and adversely from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in Aperam’s filings with the Luxembourg Stock Market Authority for the Financial Markets (Commission de Surveillance du Secteur Financier). The information is valid only at the time of release and Aperam does not assume any obligation to update or revise its forward-looking statements on the basis of new information, future events, subject to applicable regulation.

 

 

Contact

Investor Relations / Thorsten Zimmermann: IR@aperam.com
Communication / Ana Escobedo Conover: Ana.Escobedo@aperam.com



Dissemination of a Financial Wire News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


2110916  03-Apr-2025 CET/CEST

Ausgewählte Hebelprodukte auf Aperam

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aperam

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Aperam S.A.

Wer­bung

Analysen zu Aperam S.A.

DatumRatingAnalyst
23.11.2012Aperam outperformExane-BNP Paribas SA
01.11.2012Aperam holdING
31.10.2012Aperam outperformExane-BNP Paribas SA
31.10.2012Aperam buyNomura
31.10.2012Aperam neutralJ.P. Morgan Cazenove
DatumRatingAnalyst
23.11.2012Aperam outperformExane-BNP Paribas SA
31.10.2012Aperam outperformExane-BNP Paribas SA
31.10.2012Aperam buyNomura
26.10.2012Aperam outperformExane-BNP Paribas SA
25.07.2012Aperam buyING
DatumRatingAnalyst
01.11.2012Aperam holdING
31.10.2012Aperam neutralJ.P. Morgan Cazenove
29.10.2012Aperam holdING
11.10.2012Aperam holdING
22.07.2011Aperam neutralNomura
DatumRatingAnalyst
31.10.2012Aperam sellSociété Générale Group S.A. (SG)
01.10.2012Aperam sellSociété Générale Group S.A. (SG)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aperam S.A. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen